Andersons pediatric cardiology 1944

roleofliverbiopsyintheassessmentofliver
fibrosisinpatientswithFontancirculation-reply.
HumPathol.2017.
165.SchwartzMC,SullivanL,CohenMS,etal.
Hepaticpathologymaydevelopbeforethe
Fontanoperationinchildrenwithfunctional
singleventricle:anautopsystudy.JThorac
CardiovascSurg.2012;143(4):904–909.
166.WuFM,KogonB,EaringMG,etal.Liver
healthinadultswithFontancirculation:a
multicentercross-sectionalstudy.JThorac
CardiovascSurg.2017;153(3):656–664.
167.Cromme-DijkhuisAH,HessJ,HahlenK,etal.
SpecificsequelaeafterFontanoperationatmidandlong-termfollow-up.Arrhythmia,liver
dysfunction,andcoagulationdisorders.JThorac
CardiovascSurg.1993;106(6):1126–1132.
168.BaeJM,JeonTY,KimJS,etal.Fontanassociatedliverdisease:spectrumofUS
findings.EurJRadiol.2016;85(4):850–856.
169.Buendia-FuentesF,Melero-FerrerJL,PlazaLopezD,etal.Noninvasiveliverassessmentin
adultpatientswithFontancirculationusing
acousticradiationforceimpulseelastography
andhepaticmagneticresonanceimaging.World
JPediatrCongenitHeartSurg.2017
[2150135117732674].


170.ChenB,SchreiberRA,HumanDG,PottsJE,
GuttmanOR.Assessmentofliverstiffnessin
pediatricFontanpatientsusingtransient
elastography.CanJGastroenterolHepatol.
2016;2016:7125193.

171.KimSO,LeeSY,JangSI,etal.Hepaticstiffness
usingshearwaveelastographyandtherelated
factorsforaFontancirculation.PediatrCardiol.
2017.
172.PoteruchaJT,JohnsonJN,QureshiMY,etal.
Magneticresonanceelastography:anovel
techniqueforthedetectionofhepaticfibrosis
andhepatocellularcarcinomaaftertheFontan
operation.MayoClinProc.2015;90(7):882–894.
173.SugimotoM,OkaH,KajihamaA,etal.Noninvasiveassessmentofliverfibrosisbymagnetic
resonanceelastographyinpatientswith
congenitalheartdiseaseundergoingtheFontan
procedureandintracardiacrepair.JCardiol.
2016;68(3):202–208.
174.WuFM,OpotowskyAR,RazaR,etal.Transient
elastographymayidentifyFontanpatientswith
unfavorablehemodynamicsandadvanced
hepaticfibrosis.CongenitHeartDis.
2014;9(5):438–447.
175.AsraniSK,WarnesCA,KamathPS.
HepatocellularcarcinomaaftertheFontan


procedure.NEnglJMed.2013;368(18):1756–
1757.
176.ConroyMR,MoeTG.Hepatocellularcarcinoma
intheadultFontanpatient.CardiolYoung.
2017;27(2):407–409.
177.JosephusJittaD,WagenaarLJ,MulderBJ,etal.
Threecasesofhepatocellularcarcinomain

Fontanpatients:reviewoftheliteratureand
suggestionsforhepaticscreening.IntJCardiol.
2016;206:21–26.
178.Martinez-QuintanaE,MonescilloA,RodriguezGonzalezF.HepatocellularcarcinomainanonfailingFontancirculation.RevEspEnfermDig.
2017;109(5):375.
179.OhC,YounJK,HanJW,etal.Hepatocellular
carcinomaaftertheFontanprocedureina16year-oldgirl:acasereport.Medicine
(Baltimore).2016;95(41):e4823.
180.WellsML,HoughDM,FidlerJL,etal.Benign
nodulesinpost-Fontanliverscanshowimaging
featuresconsidereddiagnosticforhepatocellular
carcinoma.AbdomRadiol(NY).
2017;42(11):2623–2631.
181.HilscherMB,JohnsonJN,CettaF,etal.
Surveillanceforlivercomplicationsafterthe
Fontanprocedure.CongenitHeartDis.
2017;12(2):124–132.